By Denny Jacob
GE HealthCare trimmed its estimates for the year after assuming the impact of tariffs on its outlook.
The maker of magnetic-resonance imaging scanners and other health-care machines now expects adjusted earnings per-share to be in the range of $3.90 to $4.10. It previously guided for adjusted earnings between $4.61 a share and $4.75 a share.
Free cash flow is now expected to be at least $1.2 billion, down from prior guidance calling for at least $1.75 billion.
Chief Executive Peter Arduini said the company is actively driving mitigation actions in regards to the current global trade environment.
The Chicago company logged net income of $564 million, or $1.23 a share, up from $374 million, or 81 cents a share, in the prior-year period.
Stripping out certain one-time items, earnings came in at $1.01 a share. Analysts polled by FactSet expected 91 cents a share.
Revenue rose to $4.78 billion from $4.65 billion. Analysts polled by FactSet expected $4.66 billion.
GE HealthCare said revenue growth was broad-based with growth in each segment, with overall strength in the U.S.
GE HealthCare also announced its board authorized the repurchase of up to $1 billion of the company's common stock.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 30, 2025 07:12 ET (11:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.